JFGIW
NTLA icon

Johnson Financial Group Inc (Wisconsin)’s Intellia Therapeutics NTLA Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,988
Closed -$121K – 1043
2025
Q3 		$121K Hold
6,988
– – ﹤0.01% 425
2025
Q2 		$65.5K Buy
6,988
+1,388
+25% +$11.4K ﹤0.01% 430
2025
Q1 		$39.8K Buy
+5,600
New +$56.6K ﹤0.01% 653
2024
Q3 		– Sell
-3,856
Closed -$86.3K – 1006
2024
Q2 		$86.3K Buy
+3,856
New +$91.8K ﹤0.01% 393

Other funds holding NTLA

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s NTLA Position: Q4 2025 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Intellia Therapeutics (NTLA) in Q4 2025, closing a stake of 6,988 shares — an estimated $121K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in NTLA in Q2 2024 and held it in 4 quarters. The position peaked at $121K in Q3 2025. 293 funds tracked by Wall St. Rank hold NTLA as of Q4 2025.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Intellia Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 6,988 Intellia Therapeutics shares in Q4 2025, an estimated $121K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Intellia Therapeutics in Q2 2024 and held it in 4 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s Intellia Therapeutics position peaked at $121K in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2025.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q4 2025, filed 12 Feb 2026.